Skip to Main Content
Skip Nav Destination

Lifelong TKI therapy: how to manage cardiovascular and other risks

Hematology Am Soc Hematol Educ Program (2021) 2021 (1): 113–121.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal